These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21666718)

  • 1. Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma.
    Lo SS; Hung PS; Chen JH; Tu HF; Fang WL; Chen CY; Chen WT; Gong NR; Wu CW
    Oncogene; 2012 Jan; 31(2):226-37. PubMed ID: 21666718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
    Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
    Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.
    Zheng B; Liang L; Huang S; Zha R; Liu L; Jia D; Tian Q; Wang Q; Wang C; Long Z; Zhou Y; Cao X; Du C; Shi Y; He X
    Oncogene; 2012 Oct; 31(42):4509-16. PubMed ID: 22179828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFβ type II receptor with implications for nephropathic cell phenotypes.
    Faherty N; Curran SP; O'Donovan H; Martin F; Godson C; Brazil DP; Crean JK
    J Cell Sci; 2012 Dec; 125(Pt 23):5621-9. PubMed ID: 22976296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-429 modulates the expression of c-myc in human gastric carcinoma cells.
    Sun T; Wang C; Xing J; Wu D
    Eur J Cancer; 2011 Nov; 47(17):2552-9. PubMed ID: 21684154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
    Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
    Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
    Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
    Ding L; Xu Y; Zhang W; Deng Y; Si M; Du Y; Yao H; Liu X; Ke Y; Si J; Zhou T
    Cell Res; 2010 Jul; 20(7):784-93. PubMed ID: 20548334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
    Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D
    Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of miR-106a in gastric carcinoma and its clinical significance.
    Xiao B; Guo J; Miao Y; Jiang Z; Huan R; Zhang Y; Li D; Zhong J
    Clin Chim Acta; 2009 Feb; 400(1-2):97-102. PubMed ID: 18996365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA expression profile in undifferentiated gastric cancer.
    Katada T; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Ogawa R; Harata K; Fujii Y
    Int J Oncol; 2009 Feb; 34(2):537-42. PubMed ID: 19148490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-155 promotes gastric cancer growth and invasion by negatively regulating transforming growth factor-β receptor 2.
    Qu Y; Zhang H; Sun W; Han Y; Li S; Qu Y; Ying G; Ba Y
    Cancer Sci; 2018 Mar; 109(3):618-628. PubMed ID: 29247570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.
    Li X; Luo F; Li Q; Xu M; Feng D; Zhang G; Wu W
    Oncol Rep; 2011 Dec; 26(6):1431-9. PubMed ID: 21874264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
    Wang H; Liu J; Zong Y; Xu Y; Deng W; Zhu H; Liu Y; Ma C; Huang L; Zhang L; Qin C
    Brain Res; 2010 Oct; 1357():166-74. PubMed ID: 20709030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue.
    Kim YJ; Hwang SJ; Bae YC; Jung JS
    Stem Cells; 2009 Dec; 27(12):3093-102. PubMed ID: 19816956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of microRNA-143 and -145 in human gastric cancers.
    Takagi T; Iio A; Nakagawa Y; Naoe T; Tanigawa N; Akao Y
    Oncology; 2009; 77(1):12-21. PubMed ID: 19439999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p.
    Yang X; Wu X
    Oncol Rep; 2016 Jan; 35(1):398-408. PubMed ID: 26498065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer.
    Duan J; Zhang H; Qu Y; Deng T; Huang D; Liu R; Zhang L; Bai M; Zhou L; Ying G; Ba Y
    Oncotarget; 2016 Jul; 7(28):44522-44533. PubMed ID: 27304191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.